Global Vascular Injury Treatment Market - 2020-2027
|血管損傷治療的市場規模(2020年∼2027年) Global Vascular Injury Treatment Market - 2020-2027|
|出版日期: 2020年08月27日||內容資訊: 英文|
血管損傷治療的市場規模的成長，主要由於事故，跌倒，刀傷，骨脫位造成的血管損傷的增加所促進。在該市場中，Massachusetts General Hospital，Cleveland Clinic，Heidelberg University Hospital，Mayo Clinic Health System，Universal Health Services Inc.，IHH Healthcare Berhad，Apollo Hospitals Enterprise Ltd.，Royal Berkshire NHS Foundation Trust，Mediclinic International，Tenet Healthcare等數家公司是對成長有貢獻的主要企業。主要製造商，根據擴大血管損傷治療的生產能力，在全球強化其存在。還有主要企業，採用產品的銷售、收購、合作等幾個成長策略，推動全球市場成長。
Vascular surgery is intervention of venous, lymphatic systems, and arterial conditions of diagnosed patients. Vascular surgery is mainly done for patients suffering from some common vascular diseases, such as varicose veins, lymphatic conditions, thoracic outlet syndrome, intermittent claudication, artery malformations, hyperhidrosis, and others. Trauma caused due to the pelvis, abdomen, and retroperitoneal structures of the body is the most challenging vascular injuries. Some of the complications such as difficulty in acquiring immediate proximal control & appropriate exposure, treatment of injury in the face of contamination, and provisions for prolonged surveillance & follow-up have increased the need for vascular injury treatment. Healthcare providers in the vascular injury treatment are increasingly adopting the extra-anatomical aortic bypass graft to solve grave vascular injuries in military and emergency cases.
The global vascular injury treatment market size was worth US$ XX billion in 2018 and is estimated to reach US$ XX billion by 2027, growing at a CAGR of XX % during the forecast period (2020-2027).
The global vascular injury treatment market growth is majorly driven by the rising prevalence of vascular injuries, owing to accidents, falls, cuts, and dislocation of bones. As per the National Trauma Databank, vascular injuries hold for 1% to 2% of all the injuries in trauma patients. Penetrating trauma is one of the leading cause of peripheral vascular injuries, which accounts for over 75% of all vascular injuries in 2019. Handguns are among the major cause of penetrating injuries among penetrating vascular injuries in the United States. According to the data published in the Journal of Evolution of Medical and Dental Science, the prevalence of vascular trauma has increased over past few years, and vascular injuries account nearly 3% of all civilian trauma cases. Thus, trauma is considered to be a leading cause of vascular injury. Also, as per the Journal of Emergency and Critical Care Medicine, the annual death toll due to trauma has reached over 400,000 in China, which ranks it the fifth most common cause of death. The economic development is also leading to an increase in the number of road accidents, which is currently the most common cause of trauma.
In the United States, less than 80% of cases of vascular injury is caused by penetrating trauma, which is due to increasing usage of endovascular interventions for medical and diagnostic purposes. About 30% of vascular casualties are minimal-energy injuries, whereas high-energy injuries account for over 52% of the vascular injuries.
The rising number of injuries owing to sports injuries is further driving the market for the treatment of vascular injury. For instance, according to the CDC (Centers for Disease Control and Prevention), the high school athletes account for 2 million incidents, 50,000 visits to the doctor, and 30,000 hospital admissions in the U.S. each year.
In addition, technological advancements in endovascular techniques, magnetic resonance imagining (MRI), and CT angiography is helping by detecting vascular injuries through high sensitivity and specificity.
However, high cost is a major factor influencing the selection of treatment of the vascular injury. Obesity and morbidity increase the risk of vascular injuries which require a longer stay in hospitals, which leads to the high hospitals care cost. The cost of hospitalization for vascular injuries is comparatively higher with non-vascular injuries. For example, the cost of hospitalization for vascular injuries costs over US$ 135,500, and that of non-vascular injuries is US$ 65,000. Hence, the high cost of treatment is likely to restrain the growth of the global vascular injury treatment market.
The global vascular injury treatment market is segmented by treatment type into bypass graft, patch angioplasty, extra-anatomic bypass, lateral arteriorrhaphy/ venorrhaphy, thrombectomy, and others. Among these, the bypass graft segment is dominating the vascular injury treatment market in 2019, owing to rising incidence rates and increasing health complications associated with several vascular diseases. Some of the severe vascular disorders such as peripheral artery disease (PAD), stroke, carotid artery disease (CAD), arteriovenous malformation (AVM), pulmonary embolism, abdominal aortic aneurysm (AAA), deep vein thrombosis (DVT), critical limb ischemia (CLI), chronic venous insufficiency (CVI), and varicose veins are increasing the demand for the treatment of these disorders. According to the National Institutes of Health (NIH), around 14 million men and women are affected by coronary heart disease in the United States. It is one of the most disorder in the elderly population over 65 years old. It is caused by a waxy substance called a plaque which accumulates blood to the heart muscle in the arteries. In this, the bypass graft is the most common treatment for vascular injury to improve the poor flow of blood to the heart. This treatment reduces the risk of severe complications for individuals with obstructive coronary artery disease, a form of heart disease ischemic. Hence, the demand for bypass graft is increasing and is expected to drive the growth off market over the forecast period.
North America region is dominating the global vascular injury treatment market accounting for the largest market share in 2019, due to the rising incidence of vascular diseases and growing elderly population which is expected to create large number of opportunities for the vascular injury treatment market in the region. According to the Center for Diseases Control and Prevention (CDC), in United States, about 8.5 million people suffer from peripheral artery diseases, which accounts 12%-20% of individuals older than age 60. In addition, well-established healthcare infrastructure and technological advancements propel the vascular injury treatment market in this region.
On the other hand, the vascular injury treatment market in the Asia-Pacific is expected to grow at a significant CAGR over the forecast period, owing to increasing incidence of vascular injuries and rising government initiatives in the healthcare sector. For instnace, in 2017, according to the Ministry of Road Transport & Highways, India, a total of 464,910 road accidents were reported by the States and Union Territories (UTs), claiming 147,913 lives and causing injuries to 470,975 persons. A large number of traumatic injuries leading to vascular damage contribute to the growth of the vascular injury treatment market.
The Vascular Injury Treatment market is moderately competitive and consists of several major players. Some of the key players which are contributing to the growth of the market are Massachusetts General Hospital, Cleveland Clinic, Heidelberg University Hospital, Mayo Clinic Health System, Universal Health Services, Inc., IHH Healthcare Berhad, Apollo Hospitals Enterprise Ltd., Royal Berkshire NHS Foundation Trust, Mediclinic International, Tenet Healthcare, among others. The major manufacturers are strengthening their presence globally by expanding their production capacities in the vascular injury treatment.
The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the vascular injury treatment market globally. For instance,
The global vascular injury treatment market report would provide an access to an approx. 61 market data table, 59 figures and 290 pages.
LIST NOT EXHAUSTIVE